×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ABVX – abivax sa - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ABVX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
04:05 pm
abvx
Abivax to be Added to Nasdaq Biotechnology Index
Low
Report
Abivax to be Added to Nasdaq Biotechnology Index
12/18
09:03 am
abvx
Abivax (NASDAQ:ABVX) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Abivax (NASDAQ:ABVX) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/17
04:05 pm
abvx
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Low
Report
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
12/16
04:06 pm
abvx
Abivax (NASDAQ:ABVX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Abivax (NASDAQ:ABVX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
12/16
08:05 am
abvx
Abivax (NASDAQ:ABVX) had its price target raised by analysts at Citizens Jmp from $114.00 to $131.00. They now have a "market outperform" rating on the stock.
Low
Report
Abivax (NASDAQ:ABVX) had its price target raised by analysts at Citizens Jmp from $114.00 to $131.00. They now have a "market outperform" rating on the stock.
12/16
07:09 am
abvx
Abivax (NASDAQ:ABVX) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Abivax (NASDAQ:ABVX) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
12/15
04:07 pm
abvx
Abivax Presents Third Quarter 2025 Financial Results
Medium
Report
Abivax Presents Third Quarter 2025 Financial Results
12/13
01:10 am
abvx
Abivax (NASDAQ:ABVX) was downgraded by analysts at Wall Street Zen f
Medium
Report
Abivax (NASDAQ:ABVX) was downgraded by analysts at Wall Street Zen f
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: